Nestlé S.A. (Nestlé) announced its plans to create Nestlé Skin Health S.A., which will be formed by the acquisition of 50% of Galderma Pharma S.A. (Galderma), subject to regulatory clearance. In 1981, Galderma was established as a Swiss-based joint-venture between Nestlé and L’Oréal S. A. Humberto C. Antunes, who serves as president and chief executive officer of Galderma, will lead Nestlé Skin Health reporting to the company’s new Board of Directors. Peter Brabeck-Letmathe will become chairman and Paul Bulcke vice-chairman of the new Board of Directors of Nestlé Skin Health, based in Switzerland.
“Building on Nestlé’s historic strengths as a science based Nutrition, Health & Wellness Company and through the recent creation of Nestlé Health Science S.A., the company has reinforced its strategic direction to offer nutritional solutions from food and beverage to scientific products for a healthier life,” says Nestlé chairman Peter Brabeck-Letmathe. “By creating Nestlé Skin Health S.A. and by leveraging Galderma’s current portfolio, formulations and innovative research, Nestlé will now be able to provide science-based solutions for skin conditions. We strive to have a portfolio of innovative products that meet the full spectrum of people’s skin health needs over the course of their lives and to provide a holistic approach to people’s health.”
According to the company, the establishment of Nestlé Skin Health will allow the emergence of a global leader that will leverage Galderma’s and Nestlé’s commercial operations throughout the world. Galderma’s Scientific Division has laboratories in France, Sweden, United States, Japan and Switzerland, and it will become part of Nestlé Skin Health. Galderma will collaborate with Nestlé’s global R&D network.
“Nestlé Skin Health will have a broad commercial and R&D platform able to deliver state of the art solutions focused on maintaining, treating and restoring the health of the skin,” said Nestlé CEO Paul Bulcke. “The new company will be particularly effective working across different trade channels to help people meet their skin health needs at a time when access to medical care is getting more challenging due to resource constraints.”
Nestlé Skin Health products lines will include the skin, hair and nail products and as well as self-medication drugs, medicated soaps or sunscreens, therapeutic skin care products, nutraceuticals, prescription drugs and medical devices. Nestlé Skin Health will become operational as soon as regulatory requirements and competition authority clearance have been provided.
